Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
Actual shortage: | 46 (10%) | |
Anticipated shortage: | 15 (3%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
METOPROLOL | 100MG | TABLET | Resolved | 2020-01-22 | 2021-02-11 | 104049 |
METOPROLOL | 100MG | TABLET | Resolved | 2020-03-26 | 2021-02-11 | 109414 |
METOPROLOL | 100MG | TABLET | Resolved | 2021-06-09 | 2022-08-30 | 140607 |
TERAZOSIN | 1MG | TABLET | Resolved | 2018-03-13 | 2018-04-12 | 42542 |
TERAZOSIN | 1MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135436 |
TERAZOSIN | 2MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135430 |
TERAZOSIN | 5MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135433 |
TERAZOSIN | 10MG | TABLET | Resolved | 2017-09-27 | 2017-10-07 | 23666 |
TERAZOSIN | 10MG | TABLET | Resolved | 2018-06-28 | 2018-10-13 | 53076 |
TERAZOSIN | 10MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135439 |
NAPROXEN EC | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-25 | 2018-12-11 | 56416 |
NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-05-16 | 2018-08-16 | 49537 |
MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-29 | 2020-06-03 | 100024 |
MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-29 | 2024-03-02 | 100028 |
MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-29 | 2024-03-02 | 100031 |
LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-08-02 | 2020-02-27 | 17964 |
LORAZEPAM | 1.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135885 |
LORAZEPAM | 2.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135879 |
FAMOTIDINE | 20MG | TABLET | Resolved | 2019-10-01 | 2020-04-29 | 95094 |
FAMOTIDINE | 20MG | TABLET | Resolved | 2020-10-29 | 2024-03-02 | 127488 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
CLINDAMYCIN | 150MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4950 |
CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |
INDAPAMIDE | 1.25MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2453 |
RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3023 |